Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 8 July 2008
Vol. 1, Issue 27, p. re6
[DOI: 10.1126/scisignal.127re6]


Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities

William G. Stetler-Stevenson*

Chief, Extracellular Matrix Pathology Section, Cell and Cancer Biology Branch, Vascular Biology Faculty, Center for Cancer Research, National Cancer Institute (NCI), NIH, Advanced Technology Center, 8717 Grovemont Circle, Room 115, Bethesda, MD 20892–4605, USA.

Abstract: Over the past 20 years, the tissue inhibitors of metalloproteinases (TIMPs) have been implicated in direct regulation of cell growth and apoptosis. However, the mechanisms of these effects have been controversial. Recent work by several laboratories has identified specific signaling pathways and cell surface binding partners for members of the TIMP family. TIMP-2 binding to the integrin {alpha}3β1 is the first description of a cell surface receptor for a TIMP family member. TIMP-2 has been shown to induce gene expression, to promote G1 cell cycle arrest, and to inhibit cell migration. TIMP-1 binding to CD63 inhibits cell growth and apoptosis. These new findings suggest that TIMPs are multifunctional and can act either directly through cell surface receptors or indirectly through modulation of protease activity to direct cell fate. The emerging concept is that TIMPs function in a contextual fashion so that the mechanism of action depends on the tissue microenvironment.

*E-mail: sstevenw{at}

Citation: W. G. Stetler-Stevenson, Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities. Sci. Signal. 1, re6 (2008).

Read the Full Text

G. M. Thornton, C. R. Reno, I. K. Y. Lo, and D. A. Hart (2013)
Br. J. Sports Med. 47, e2
   Abstract »    PDF »
Abnormal recruitment of extracellular matrix proteins by excess Notch3ECD: a new pathomechanism in CADASIL.
M. Monet-Lepretre, I. Haddad, C. Baron-Menguy, M. Fouillot-Panchal, M. Riani, V. Domenga-Denier, C. Dussaule, E. Cognat, J. Vinh, and A. Joutel (2013)
Brain 136, 1830-1845
   Abstract »    Full Text »    PDF »
Membrane-Associated Matrix Proteolysis and Heart Failure.
F. G. Spinale, J. S. Janicki, and M. R. Zile (2013)
Circ. Res. 112, 195-208
   Abstract »    Full Text »    PDF »
Antagonism of VEGF-A-induced increase in vascular permeability by an integrin {alpha}3{beta}1-Shp-1-cAMP/PKA pathway.
S. H. Kim, Y.-R. Cho, H.-J. Kim, J. S. Oh, E.-K. Ahn, H.-J. Ko, B. J. Hwang, S.-J. Lee, Y. Cho, Y. K. Kim, et al. (2012)
Blood 120, 4892-4902
   Abstract »    Full Text »    PDF »
Early-Outgrowth Bone Marrow Cells Attenuate Renal Injury and Dysfunction via an Antioxidant Effect in a Mouse Model of Type 2 Diabetes.
Y. Zhang, D. A. Yuen, A. Advani, K. Thai, S. L. Advani, D. Kepecs, M. G. Kabir, K. A. Connelly, and R. E. Gilbert (2012)
Diabetes 61, 2114-2125
   Abstract »    Full Text »    PDF »
Folic acid and safflower oil supplementation interacts and protects embryos from maternal diabetes-induced damage.
R. Higa, M. Kurtz, M. B. Mazzucco, D. Musikant, V. White, and A. Jawerbaum (2012)
Mol. Hum. Reprod. 18, 253-264
   Abstract »    Full Text »    PDF »
Knockdown of Hoxa11 In Vivo in the Uterosacral Ligament and Uterus of Mice Results in Altered Collagen and Matrix Metalloproteinase Activity.
Y. Ma, M. Guess, A. Datar, A. Hennessey, I. Cardenas, J. Johnson, and K. A. Connell (2012)
Biol Reprod 86, 100
   Abstract »    Full Text »    PDF »
Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/{beta}-catenin signaling.
V. Egea, S. Zahler, N. Rieth, P. Neth, T. Popp, K. Kehe, M. Jochum, and C. Ries (2012)
PNAS 109, E309-E316
   Abstract »    Full Text »    PDF »
BRAFV600E mutation, TIMP-1 upregulation, and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy.
A. Bommarito, P. Richiusa, E. Carissimi, G. Pizzolanti, V. Rodolico, G. Zito, A. Criscimanna, F. Di Blasi, M. Pitrone, M. Zerilli, et al. (2011)
Endocr. Relat. Cancer 18, 669-685
   Abstract »    Full Text »    PDF »
Prognostic Significance of TIMP-1 in Non-small Cell Lung Cancer.
Anticancer Res 31, 4031-4038
   Abstract »    Full Text »    PDF »
Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.
S. S. Siller and K. Broadie (2011)
Dis. Model. Mech. 4, 673-685
   Abstract »    Full Text »    PDF »
Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections.
H. Hamdi, V. Planat-Benard, A. Bel, E. Puymirat, R. Geha, L. Pidial, H. Nematalla, V. Bellamy, P. Bouaziz, S. Peyrard, et al. (2011)
Cardiovasc Res 91, 483-491
   Abstract »    Full Text »    PDF »
I{kappa}B{beta} Attenuates Angiotensin II-Induced Cardiovascular Inflammation and Fibrosis in Mice.
S. Xu, H. Zhi, X. Hou, R. A. Cohen, and B. Jiang (2011)
Hypertension 58, 310-316
   Abstract »    Full Text »    PDF »
TIMP-1 deficiency subverts cell-cycle dynamics in murine long-term HSCs.
L. Rossi, A. V. Ergen, and M. A. Goodell (2011)
Blood 117, 6479-6488
   Abstract »    Full Text »    PDF »
Glial cell missing-1 mediates over-expression of tissue inhibitor of metalloproteinase-4 in severe pre-eclamptic placental villi.
S. Drewlo, M. Czikk, D. Baczyk, S. Lye, and J. Kingdom (2011)
Hum. Reprod. 26, 1025-1034
   Abstract »    Full Text »    PDF »
Astrocytic Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Promotes Oligodendrocyte Differentiation and Enhances CNS Myelination.
C. S. Moore, R. Milner, A. Nishiyama, R. F. Frausto, D. R. Serwanski, R. R. Pagarigan, J. L. Whitton, R. H. Miller, and S. J. Crocker (2011)
J. Neurosci. 31, 6247-6254
   Abstract »    Full Text »    PDF »
Angiogenic Biomarkers and Healing of Living Cellular Constructs.
T. Morelli, R. Neiva, M. L. Nevins, M. K. McGuire, E. T. Scheyer, T.- J. Oh, T. M. Braun, J. E. Nor, D. Bates, and W. V. Giannobile (2011)
Journal of Dental Research 90, 456-462
   Abstract »    PDF »
Tissue Inhibitor of Matrix-Metalloprotease-1 Predicts Risk of Hepatic Fibrosis in Human Schistosoma japonicum Infection.
V. Fabre, H. Wu, S. PondTor, H. Coutinho, L. Acosta, M. Jiz, R. Olveda, L. Cheng, E. S. White, B. Jarilla, et al. (2011)
The Journal of Infectious Disease 203, 707-714
   Abstract »    Full Text »    PDF »
Reduced TIMP-2 in hypoxia enhances angiogenesis.
N. Lahat, H. Bitterman, M. Engelmayer-Goren, D. Rosenzweig, L. Weiss-Cerem, and M. A. Rahat (2011)
Am J Physiol Cell Physiol 300, C557-C566
   Abstract »    Full Text »    PDF »
Biomarkers Predicting Outcome in Patients with Advanced Renal Cell Carcinoma: Results from Sorafenib Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.
C. Pena, C. Lathia, M. Shan, B. Escudier, and R. M. Bukowski (2010)
Clin. Cancer Res. 16, 4853-4863
   Abstract »    Full Text »    PDF »
Requirement for Inducible Nitric Oxide Synthase in Chronic Allergen Exposure-Induced Pulmonary Fibrosis but Not Inflammation.
A. S. Naura, M. Zerfaoui, H. Kim, Z. Y. Abd Elmageed, P. C. Rodriguez, C. P. Hans, J. Ju, Y. Errami, J. Park, A. C. Ochoa, et al. (2010)
J. Immunol. 185, 3076-3085
   Abstract »    Full Text »    PDF »
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-{beta}1b.
J. Alexander, M. Harris, S. Wells, G. Mills, K. Chalamidas, V. Ganta, J. McGee, M. Jennings, E. Gonzalez-Toledo, and A. Minagar (2010)
Multiple Sclerosis Journal 16, 801-809
   Abstract »    PDF »
Effect of TIMP-1 and MMP in Pterygium Invasion.
Y.-Y. Tsai, C.-C. Chiang, K.-T. Yeh, H. Lee, and Y.-W. Cheng (2010)
Invest. Ophthalmol. Vis. Sci. 51, 3462-3467
   Abstract »    Full Text »    PDF »
Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway.
L. S. Adams, S. Phung, N. Yee, N. P. Seeram, L. Li, and S. Chen (2010)
Cancer Res. 70, 3594-3605
   Abstract »    Full Text »    PDF »
H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure.
P. K. Mishra, N. Tyagi, U. Sen, S. Givvimani, and S. C. Tyagi (2010)
Am J Physiol Heart Circ Physiol 298, H451-H456
   Abstract »    Full Text »    PDF »
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer.
R. Roy, J. Yang, and M. A. Moses (2009)
J. Clin. Oncol. 27, 5287-5297
   Abstract »    Full Text »    PDF »
The Use of Predictive or Prognostic Genetic Biomarkers in Endometrial and Other Hormone-Related Cancers: Justification for Extensive Candidate Gene Single Nucleotide Polymorphism Studies of the Matrix Metalloproteinase Family and their Inhibitors.
T. A. O'Mara, J. A. Clements, and A. B. Spurdle (2009)
Cancer Epidemiol. Biomarkers Prev. 18, 2352-2365
   Abstract »    Full Text »    PDF »
Breast Tumor Cells Transendothelial Migration Induces Endothelial Cell Anoikis Through Extracellular Matrix Degradation.
Anticancer Res 29, 2347-2355
   Abstract »    Full Text »    PDF »
Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity.
M. Sieber, D. Hoffmann, M. Adler, V. S. Vaidya, M. Clement, J. V. Bonventre, N. Zidek, E. Rached, A. Amberg, J. J. Callanan, et al. (2009)
Toxicol. Sci. 109, 336-349
   Abstract »    Full Text »    PDF »
Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.
P. Garg, M. Vijay-Kumar, L. Wang, A. T. Gewirtz, D. Merlin, and S. V. Sitaraman (2009)
Am J Physiol Gastrointest Liver Physiol 296, G175-G184
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882